Ketorolac causes the release of methionine-enkephalin in rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 91, Issue 2, 1996, Pages 249-252

  Michel, Robert E ^a   Holt, Joseph C ^a   Domer, Floyd R ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC; METENKEPHALIN; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE RECEPTOR;

ANALGESIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENKEPHALIN, METHIONINE; KETOROLAC; MALE; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; TOLMETIN;

EID: 0029995059     PISSN: 00345164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chan TT and Weichman BM (1989). Pemedolac: a novel and long-acting non-narcotic analgesic. J. Pharmacol. Exp. Ther. 248:907-915
2. Domer F (1990). Characterization of the analgesic activity of ketorolac in mice. Eur. J. Pharmacol. 177:127-135.
3. Ferriera SH, Lorenzetti BB, Devissagnet M, Lesieur D and Tsoerderos Y. (1995) S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance. Br. J. Pharmacol. 1114:303-308.
4. Granados-Soto V, Flores-Murrieta FJ, Castaneda-Hernandez G, Hong E, and Lopez-Muňoz FJ. (1995) Evidence against the participation of μ- and κ- opioid receptors in the analgesic activity of ketorolac in rats. J Pharm. Pharmacol 47:524-517.
5. Hardman J, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG, Eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. Ninth Ed., New York, Pergamon Press, 1996:1763.
6. Lopez M, Waterbury A, and Michel A. (1987) Lack of addictive potential of ketorolac tromethamine. Pharmacologist 29:136.
7. Miranda HF, Sierralta F and Pinardi G. (1993). Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice Anesth. Analg. 77:750-753.
8. USP DI, sixteenth edition, Vol. I, 1996; 1824.
9. Uphouse LA, Welch SP, Ward CR, Ellis EF and Embrey JP. (1993). Antinociceptive activity of intrathecal ketorolac is blocked by the κ-opioid receptor antagonist, norbinaltorphimine. Eur. J. Pharmacol. 242:53-58
10. Yee JR, Bradley R, Stanski D and Cherry C. (1986). A comparison of analgesic efficacy of intramuscular ketorolac tromethamine and meperidine in postoperative pain. Clin. Pharmacol. Ther. 39.237.